Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer
Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1589869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Ziyang Zeng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Body Composition, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obesity and overweight have been suggested as a potential predictor of favorable outcomes in certain malignancies treated with immunotherapy. However, most studies have relied on BMI as a proxy for adiposity, without fully considering the distinct roles of fat and lean tissues. This study aimed to explore the association between body composition and treatment response in colorectal cancer patients receiving neoadjuvant PD-1 inhibitor therapy.
Methods
Patients with dMMR/MSI-H colorectal cancer undergoing neoadjuvant PD-1 blockade were included in this study. Body composition parameters were measured using baseline CT images. Pathological response was assessed using tumor regression grade (TRG). Univariate and multivariate analyses were performed to examine the association between body composition variables (total adipose tissue, visceral adipose tissue, subcutaneous adipose tissue, visceral-to-subcutaneous adipose tissue ratio, and skeletal muscle) and pathological complete response (pCR) rates. Correlation analysis was conducted to detect the relationship between body composition and lipid profiles.
Results
A total of 84 patients were included in the analysis. Patients with poor treatment response exhibited significantly lower levels of visceral adipose tissue (VAT), total adipose tissue (TAT), and BMI. On multivariate analysis, higher VAT volume and elevated circulating lymphocyte count were independently associated with increased pCR rates. The positive association between VAT and treatment response was consistent across most subgroups except in patients aged ≥ 65, where the effect tended to be reversed. Additionally, VAT volume correlated positively with triglycerides and negatively with high-density lipoprotein cholesterol.
Conclusion
Higher visceral adipose tissue volume is associated with improved pathological complete response in dMMR/MSI-H colorectal cancer patients treated with PD-1 inhibitors. However, this favorable effect of visceral adiposity may be diminished or reversed in elderly patients (≥ 65 y), highlighting the potential influence of aging on the metabolic-immune interplay in immunotherapy response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
- South China Hospital, Medical School, Shenzhen University, Shenzhen, China.
- Department of Thyroid & Galactophore Surgery, People's Hospital of Longhua, Shenzhen, China.
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Department of Radiology, Sun Yat-sen…
Zitieren
APA
Zeng, Z., Zhou, J., Zhang, W., Peng, J., Li, Y., Jin-Si-Han, E. E., Wang, H., Lian, S., Feng, C., Xie, C., Pan, Z., & Lu, Z. (2025). Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1589869
Vancouver
Zeng Z, Zhou J, Zhang W, Peng J, Li Y, Jin-Si-Han EE, et al. Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1589869
BibTeX
@article{Zeng2025,
author = {Zeng, Ziyang and Zhou, Jian and Zhang, Weili and Peng, Jianhong and Li, Yuan and Jin-Si-Han, E-Er-Man-Bie-Ke and Wang, Hao and Lian, Shaopu and Feng, Cheng and Xie, Chuanmiao and Pan, Zhizhong and Lu, Zhenhai},
title = {Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer},
journal = {Frontiers in Immunology},
year = {2025},
doi = {10.3389/fimmu.2025.1589869}
}
EUVIMED